Full Text View
Tabular View
Study Results
Related Studies
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
This study has been completed.
Study NCT00750152   Information provided by Merz Pharmaceuticals, LLC

First Received on September 9, 2008.   Last Updated on April 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tinea Cruris
Jock Itch
Additional conditions recognized in this trial
Tinea
More general conditions related to this trial
Dermatomycoses
Infection
Mycoses
Skin Diseases
Skin Diseases, Infectious
Interventions listed in this trial
NAFT-500
Placebo
Sponsors listed in this trial
Merz Pharmaceuticals, LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services